Economics at the FTC: Pharmaceutical Patent Dispute Settlements and Behavioral Economics |
| |
Authors: | Michael A Salinger Pauline M Ippolito Joel L Schrag |
| |
Institution: | (1) Federal Trade Commission, Bureau of Economics, 600 Pennsylvania Ave. N.W., Washington, DC 20580, USA |
| |
Abstract: | Economics at the Federal Trade Commission (FTC) supports both the competition and consumer protection missions of the agency.
In this year’s essay we discuss two issues, one from each of the agency’s missions. First, we focus on intellectual property
issues in pharmaceuticals. Specifically, we discuss the principal rationale for antitrust concerns about certain patent dispute
settlements in the ethical drug industry. Then, we discuss consumer economics, our recent behavioral economics conference,
and how behavioral economics influences our thinking about consumer policy. |
| |
Keywords: | Antitrust Behavioral economics Consumer protection FTC Patents Pharmaceuticals |
本文献已被 SpringerLink 等数据库收录! |
|